Zimmer Biomet CEO turns focus to robotics: 6 things to know about Bryan Hanson

Alan Condon -   Print  |

In 2015, Zimmer Biomet was established through the merger of Zimmer and Biomet. Two years later, the company appointed Bryan Hanson as president and CEO.

Here are six things to know about Mr. Hanson:

1. Before joining Zimmer Biomet in 2017, Mr. Hanson operated as executive vice president and president of the minimally invasive therapies group at Medtronic.

2. Over a 22-year period, he held several leadership roles at Covidien, including group president of surgical solutions, president of energy-based devices and president of U.S. medical devices, before the company was acquired by Medtronic in 2015.

3. Last year, under Mr. Hanson's leadership, Zimmer Biomet gained FDA approval for The Tether, an anterior vertebral body tethering treatment for pediatric scoliosis. He also led the ROSA ONE Spine System, ROSA One Brain application and ROSA Knee System to FDA clearance.

4. Mr. Hanson expects robotics to play a big role for Zimmer Biomet this year. "Our innovation focus has also shifted, moving much more aggressively toward enabling technology around the implant, such as robotics, mini robotics, informatics and operating room efficiency," he said during the third quarter earnings call in November. "Although the implant will always be at the center of what we do, our goal is to provide a complete ecosystem that is both customer and patient centric."

5. Graduating with a degree in finance from Florida State University, Mr. Hanson later completed the Kellogg School of Management Finance for Executives at Northwestern University in Chicago as well as the Harvard Executive Education in Leadership program, according to his LinkedIn profile.

6. Zimmer Biomet reported a slight increase in fourth quarter and full year sales in 2019, with strong performances in hips, knees and robotic system sales. Full year sales were up 0.8 percent to nearly $8 billion, while full year spine and craniomaxillofacial sales decreased 2.2 percent to $747 million. Mr. Hanson expects the company's reported revenue to increase 2.5 percent to 3.5 percent in 2020.

More articles on devices:
Stryker ranks No. 8 in Fortune's 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers